A medication used to treat the disorder hyperactivity disorder (ADHD) treated by a Québece medical team is listening to the high rate prescribed by the medication.
Patients between the ages of 13 and 17 years old, ADHD drugs are prescribed more than twice in other provinces, the doctors said.
The 45 doctors from Québec opened an open letter that opened on Friday, and the public looked at the problem.
This letter does not take urgent consideration for why we do not use large prescription drugs, however, because so many young people do not show attention, hyperactivity, impulsivity, and anxiety symptoms.
We feel a great deal of pressure on only the medication to deal with the problems that work with a vulnerable pediatric population, that is, not the right solution.– Dr. Gilles Julien, expert in social pediatrics
The group regains its claim with data from the National Institute of Excellence in Health and Social Services of the province (INESSS) – Quebec's ADHD drug prescription rate is being disturbed.
In the case of young people between the ages of 13 and 17, those who cover the drug insurance plan in the province, the prescription rates fell from 3.4% to 9.9% between 2006 and 2015.
In the case of Quebec between 0 and 25, the numbers exceed the rest of the countries.
In 0 to 25 groups, regardless of whether they were private or public drug insurance, INESSS data shows that in 2014-2015, the percentage of children with ADHD for the treatment of medication was 6.4% in Québec, 2.4 percent in other Canadian countries.
The highest rate of medication is given to children from 10 to 12 years of age, the letter indicates that children have 14% of ADHD medications, with more than five percent of Canadians.
Doctors say drug treatment may be effective in the short term, but it may have negative effects over the long term.
The team is pushing for teachers, parents, and healthcare professionals, who are thinking about choosing to medicate their children and adolescents, as well as psychosocial intervention and parental support.
We feel a lot of pressure & # 39;
Dr. Gilles Julien is a pioneer in the field of social pediatrics in Quebec between those who signed the letter.
CBC said in Montreal Daybreak On Thursday, medicines similar to methylphenidate, which are commonly referred to as Ritalin, are in many cases worked, but drugs are less effective when the patient's condition is more complex.
"For people, medication is like a solution," he said. "It's not the only solution. We feel the feeling of pressure that works with a weak pediatric population to only solve medication, but it is not the right solution."
It's not clear why Quebec prescribes drugs more than twice the rate of other provinces, he said.
However, there is a lot of pressure on doctors, doctors, parents, and other people who work with children to give medication.
This type of pressure is not felt in Europe or in other parts of Canada, he said.
Listen to the full interview with Gilles Julien here:
Julien says that children are getting worse and worse. They are receiving support from schools, they said, and they did not have the same access, as in previous music and sports generations.
These activities help to reduce anxiety, he said.
Doctors warn of excessive prescription and over-diagnosis
Radio interview in Canada Gravel will kill youDr. Valérie Labbé also signed letters, saying she wanted to have a full public debate about her childhood drug addiction.
In general, society has to think about the subject, but before the doctors or parents have blamed it, he said.
Quebec may have been prescribed more than just drugs prescribed by Ritalin that pay for universal drug insurance plans in the province, which do not have other provinces.
"When we talk, when [doctors] Check them out, everyone is frightened by this high rate of medication, "said Labb.
"It's a social phenomenon, children are still struggling to concentrate and manage their emotions."
Dr. Stacey Bélanger, a pediatric mental health mentor at the Sainte-Justine Hospital in Montreal, has warned that further investigations should be made about country disagreements regarding prescription rates and drug impact.
One of the major conflicts, he said, is that drugs are not covered in other countries, often making Canada's Canadian Canadian unmanageable.
"For example, long-acting psychomoulders are not covered in British Columbia," he said in a statement.